Pierre J. Ousset
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Cognitive Stability Among Plasma p-tau 181 Negative Individuals: A 5-year Analysis of the Multidomain Alzheimer Prevention Trial Study.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: November 09, 2024
Immunotherapies in Alzheimer's disease: state of the art and potential use in the elderly
Journal: Geriatrie et psychologie neuropsychiatrie du vieillissement
Published: July 31, 2023
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint.
Journal: The Lancet regional health. Europe
Published: March 01, 2023
Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
Journal: Journal of Alzheimer's disease : JAD
Published: May 26, 2019
Potentially modifiable factors associated with agitation and aggression in Alzheimer's disease: results of the ICTUS study.
Journal: International psychogeriatrics
Published: February 05, 2019
Incident Cerebral Microbleeds Detected by Susceptibility Weight-Imaging Help to Identify Patients with Mild Cognitive Impairment Progressing to Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: August 23, 2017
Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease.
Journal: The Journal of clinical psychiatry
Published: September 23, 2015
Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design.
Journal: International psychogeriatrics
Published: September 17, 2014
Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 06, 2014
Should interventions to treat or prevent Alzheimer's disease be tested in a population or as targeted treatment of highly selected study participants?
Journal: Alzheimer's research & therapy
Published: December 12, 2013
Gantenerumab for the treatment of Alzheimer's disease.
Journal: Expert opinion on biological therapy
Published: May 16, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026